has been and continues to be a pioneer in research into combined hormonal therapy and chemotherapy, timing and duration of adjuvant therapies, assessment of quality of life of breast cancer patients, tailored treatment investigations, evaluating endocrine therapies and translational research.
Additional information regarding BIG 1-98 and IBCSG
can be found on the Web site www.
Rum Ekhtiar of Ruder Finn, +1-212-593-5821, Mobile: +1-917-331-1690, for IBCSG
; or Nadia Munarini, PhD of IBCSG
, +41-31-389-92-27, Mobile: +41-79-207-45-82
Rum Ekhtiar of Ruder Finn, +1-212-593-5821, mobile, +1-917-331-1690, for The International Breast Cancer Study Group; Nadia Munarini, PhD, of IBCSG
+41-31-389-92-27, mobile, +41-79-207-45-82
has traditionally performed studies in special populations such as older women.
is headquartered in Bern as a foundation under Swiss law.
CONTACT: Nadia Munarini, PhD, IBCSG
, +41-31-389-92-27, or nadia.